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Background: Exercise is a core component of the physiotherapy management of children with cystic fibrosis 
(CF), but studies involving unsupervised exercise training have failed to show consistent benefits. 
Purpose: To evaluate the effects of a 24-month, individually prescribed, supervised, weekly exercise 
intervention on FEV1, Lung Clearance Index (LCI), exercise capacity (VO2Peak and 10m-Modified 
Shuttle Walk distance) and quality of life (CFQ-R) in children with CF. 
Methods: Children aged 6-15 years were randomised by minimisation into control or intervention groups. Both 
groups received specialist CF care; the intervention group also received a weekly supervised 
exercise programme (aerobic, strength and core-conditioning) for 24-months. 
Results: Of 71 children enrolled in the study, aged 10±3 years (mean±SD; range 6-15), with a range of lung 
disease severity (FEV1 z-scores: -1.10±1.23; FEV1 86.6±15.3%pred), 4 dropped out (1:control; 
3:intervention). 67 completed the study (control:33, intervention:34). 
 
Data at baseline and 24-months respectively, for all participants are presented in the 
format: Control: baseline to 24-months vs Intervention: baseline to 24-months; adjusted mean 
between group difference (95% CI) with statistical significance (**) or non-significance (NS). 
 FEV1 z-scores: -1.32 to -1.55 vs -0.89 to -1.1; diff=0.12 (-0.4,0.6), NS 
 FEV1: 83.8 to 81.3%pred vs 89.2 to 86.8%pred; diff=1.4% (-4.9,7.6), NS 
 LCI: 9.6 to 10.3 vs 8.6 to 8.9; diff= -0.8 (-1.9,0.3), NS 
 VO2Peak: 36.9 to 42.5ml.kg.min-1 vs 36.1 to 43.5ml.kg.min-1; diff=1.4 (-1.8,4.5), NS 
 10m-MSWT distances: 963m to 1024m vs 916m to 1182m; diff= 225m (148,302), p< 
0.001** 
 CFQ-R Physical: 89 to 85 vs 84 to 88: diff= 9% (-0.5,18; p=0.06), NS 
 CFQ-R Respiratory: 82 to 74 vs 80 to 82: diff=6.5% (-4,17), NS 
 CFQ-R Treatment burden: 77 to 71 vs 67 to 76: diff=13% (3,22), p=0.01** 
 CFQ-R Overall quality of life: 82 to 78 vs 77 to 80: diff=6% (1,10), p=0.01** 
After adjusting for minimisation factors, there were significant and clinically important between 
group differences in 10m-MSWT and CFQ-R (treatment burden and overall quality of life domains), 
in favour of the intervention group. FEV1 and LCI scores deteriorated slightly and VO2Peak 
improved >15% in both groups over 24-months, with no significant between group differences. 
There was variability in participant attendance and a significant dose related effect of 'number of 
weeks trained' on change in FEV1 was observed, indicating that for every 52 weeks trained (one 
training session per week for a year), participants would expect to see an increase in FEV1 z-score 
by 0.83 (0.03,1.56; p< 0.04**) compared with the control group, which equates to an improvement 
of >10%. 
Conclusion(s): INSPIRE-CF has demonstrated that a supervised weekly exercise programme for children with CF 
can result in significant and clinically important improvements in 10m-MSWT scores and quality of 
life measures. Further analysis of study data will clarify relationships between exercise, hospital 
admissions and costs of health care. 
Implications: Health care provision for children with CF should incorporate personally prescribed and supervised 
exercise as part of their overall management. Regular exercise routines established in childhood, 
may facilitate optimal self-management health behaviours into adulthood. Although FEV1, LCI or 
VO2Peak did not improve, the significant dose related benefit to FEV1 could assist in prescribing 
minimum threshold exercise levels in future. 
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